Kainos Medicine Inc (284620) — Cash Flow Reinvestment Rate

Latest as of June 2019: 0.00x

Kainos Medicine Inc (284620) has a Cash Flow Reinvestment Rate of 0.00x as of June 2019, reinvesting ₩0.00 (capex ₩0.00 ) from operating cash flow of ₩208.76 Million. See Kainos Medicine Inc (284620) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

₩0.00

Capex + Investments

Operating Cash Flow

₩208.76 Million

KRW

Capital Expenditures

₩0.00

KRW

Kainos Medicine Inc Cash Flow Reinvestment Rate (2019–2019)

Historical reinvestment intensity for Kainos Medicine Inc across 1 annual periods. For the full cash flow conversion analysis, see Kainos Medicine Inc (284620) cash flow conversion.

Annual Cash Flow Reinvestment Rate for Kainos Medicine Inc (2019–2019)

Year-by-year capital reinvestment analysis for Kainos Medicine Inc. See financial agility of Kainos Medicine Inc to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (KRW)	Operating CF	Capex	YoY Change
2019	0.00x	₩0.00	₩185.74 Million	₩0.00	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow